Literature DB >> 2162329

Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages.

R N Apte1, S K Durum, J J Oppenheim.   

Abstract

In the present study, we have assessed the effect of opioids (endorphins, enkephalins and neoendorphins) on production of IL-1 activity by bone-marrow-derived macrophages. None of the neuropeptides induced IL-1 production by itself. However, some of the opioids potentiated IL-1 production and release in macrophages concomitantly stimulated by lipopolysaccharide (LPS) or silica. LPS induced predominantly intracellular IL-1 activity, whereas most of the silica-induced IL-1 was released extracellularly. beta-Endorphin, leucine-enkephalin (leu-enkephalin) and beta-neoendorphin all potentiated both intracellular and extracellular release of IL 1 induced by either LPS or silica. In contrast, alpha-endorphin, methionine-enkephalin (metenkephalin) and alpha-neoendorphin did not influence IL-1 production or release. The potentiating effects of beta-endorphin on LPS-induced IL-1 production/secretion were inhibited by naloxone, pointing to an involvement of opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162329     DOI: 10.1016/0165-2478(90)90026-m

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  11 in total

Review 1.  Detection and function of opioid receptors on cells from the immune system.

Authors:  J M Bidlack
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 2.  Opioid receptors and signaling on cells from the immune system.

Authors:  Jean M Bidlack; Maxim Khimich; Amy L Parkhill; Sarah Sumagin; Baoyong Sun; Christopher M Tipton
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-08       Impact factor: 4.147

3.  Opioid-induced chemokine expression requires NF-κB activity: the role of PKCζ.

Authors:  Christine Happel; Michele Kutzler; Thomas J Rogers
Journal:  J Leukoc Biol       Date:  2010-10-15       Impact factor: 4.962

Review 4.  The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Authors:  Martin L Dalefield; Brittany Scouller; Rabia Bibi; Bronwyn M Kivell
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

5.  The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis.

Authors:  T J Hall; B Jagher; M Schaeublin; I Wiesenberg
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

6.  Regulation of interleukin-1beta and interleukin-8 production by agonists of mu and delta opiate receptors in vitro.

Authors:  S V Gein; K G Gorshkova; S P Tendryakova
Journal:  Neurosci Behav Physiol       Date:  2009-06-11

Review 7.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

8.  Kappa Opioid Receptor Expression and Function in Cells of the Immune System.

Authors:  Thomas J Rogers
Journal:  Handb Exp Pharmacol       Date:  2022

9.  The opioid peptide dynorphin A induces leukocyte responses via integrin Mac-1 (αMβ2, CD11b/CD18).

Authors:  Nataly P Podolnikova; Julie A Brothwell; Tatiana P Ugarova
Journal:  Mol Pain       Date:  2015-06-03       Impact factor: 3.395

10.  Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice.

Authors:  Megumi Aita; Margaret R Byers; Charles Chavkin; Mei Xu
Journal:  Mol Pain       Date:  2010-01-29       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.